Zhang; Mei-Yun

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhang; Mei-Yun.The latest application filed is for "broadly cross-reactive hiv-1-specific antibodies for prevention and treatment of hiv".

Company Profile

1.11.14

Zhang; Mei-Yun - Hong Kong HK
Zhang; Mei-Yun - Frederick MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Broadly cross-reactive HIV-1-specific antibodies for prevention and treatment of HIV Grant 11,124,561 - Zhang September 21, 2	2021-09-21
Broadly Cross-reactive Hiv-1-specific Antibodies For Prevention And Treatment Of Hiv App 20190185549 - Zhang; Mei-Yun	2019-06-20
Broadly cross-reactive HIV-1 Env-specific antibodies Grant 10,280,213 - Zhang	2019-05-07
Anti-HER2 and anti-IGF-IR BI-specific antibodies and uses thereof Grant 9,481,729 - Zhang November 1, 2	2016-11-01
Anti-her2 And Anti-igf-ir Bi-specific Antibodies And Uses Thereof App 20150071927 - Zhang; Mei-Yun	2015-03-12
Anti-IGF-IR antibodies and uses thereof Grant 8,444,982 - Zhang May 21, 2	2013-05-21
Broadly Cross-reactive Hiv-1-specific Antibodies For Prevention And Treatment Of Hiv App 20130011414 - Zhang; Mei-Yun	2013-01-10
Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency Grant 8,110,192 - Dimitrov , et al. February 7, 2	2012-02-07
Anti-igf-ir Antibodies And Uses Thereof App 20110135663 - ZHANG; MEI-YUN	2011-06-09
Identification Of Novel Broadly Cross-reactive Neutralizing Human Monoclonal Antibodies Using Sequential Antigen Panning Of Phage Display Libraries App 20100317837 - Dimitrov; Dimiter S. ; et al.	2010-12-16
Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries Grant 7,803,913 - Dimitrov , et al. September 28, 2	2010-09-28
Human Immunodeficiency Virus-neutralizing Antibodies With Improved Breadth And Potency App 20090291493 - Dimtrov; Dimiter S. ; et al.	2009-11-26
Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency Grant 7,566,451 - Dimitrov , et al. July 28, 2	2009-07-28
Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes Grant 7,378,093 - Dimitrov , et al. May 27, 2	2008-05-27
A32 Monoclonal Antibody Fusion Proteins For Use As Hiv Inhibitors And Vaccines App 20080038280 - Dimitrov; Dimiter S. ; et al.	2008-02-14
Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies App 20070292390 - Dimitrov; Dimiter S. ; et al.	2007-12-20
Broadly Cross-reactive Neutralizing Antibodies Against Human Immunodeficiency Virus Selected By Env-cd4-co-receptor Complexes App 20070212349 - Dimitrov; Dimiter S. ; et al.	2007-09-13
Immunoglobulins with Potent and Broad Antiviral Activity App 20070212363 - Dimitrov; Dimiter S. ; et al.	2007-09-13
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by Env-CD4-co-receptor complexes Grant 7,223,844 - Dimitrov , et al. May 29, 2	2007-05-29
Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal Antibodies App 20050164166 - Dimitrov, Dimiter S ; et al.	2005-07-28
Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries App 20050123900 - Dimitrov, Dimiter S ; et al.	2005-06-09
Immunoglobulin having particular framework scaffold and methods of making and using App 20050037420 - Zhang, Mei-Yun ; et al.	2005-02-17
Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes App 20040259075 - Dimitrov, Dimiter S. ; et al.	2004-12-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.